跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
miriplatin
首页
药物
miriplatin
miriplatin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Miriplatin freeze-dried powder injection and preparation method thereof
CN 102266297 B
申请人: JIANSU AOSHIKANG PHARMACEUTICAL CO LTD
优先权: 2011
CN
Miriplatin for injection and preparation method thereof
CN 104188925 A
申请人: SHANGDONG NEW TIME PHARM PROD
优先权: 2014
CN
Medicinal agent-containing molecular assembly which uses amphiphilic block polymer
US 11224578 B2
申请人: SHIMADZU CORP
优先权: 2016
US
Preparation method of platinum anti-tumor drug miriplatin oxide
CN 106946946 A
申请人: KUNMING GUIYAN PHARMACEUTICAL CO LTD
优先权: 2017
CN
Albumin nanoparticle composition containing miriplatin and preparation method thereof
CN 109730998 A
申请人: INST MED BIOTECHNOLOGY CAMS
优先权: 2018
CN
Paclitaxel-platinum (IV) compound, intermediate, preparation method and application
CN 112225758 A
申请人: UNIV JIANGSU SCIENCE & TECH
优先权: 2020
CN
Application of miriplatin lipidosome in resisting drug-resistant tumors
CN 115957188 A
申请人: INST MED BIOTECHNOLOGY CAMS
优先权: 2021
CN
Losartan-platinum (IV) compound as well as preparation method and application thereof
CN 118359668 A
申请人: UNIV JIANGSU SCIENCE & TECH
优先权: 2024
CN
一种中药组合物制剂与米铂联合用药在制备乳腺癌治疗药物中的应用
CN 121313725 B
申请人: 上海市中医医院
优先权: 2025
CN
药物
反馈